nathan davis executive director medreleaf australia drive change

Our GPs are continually frustrated by the current driving laws that prevent them from offering a safe and effective alternative to commonly prescribed and sedating compounds such as opioids and benzodiazepines. We need to have confidence that GPs are more than capable of managing a patients therapy, whether the patient wishes to drive to work or otherwise.

Nathan Davis

Executive Director, MedReleaf Australia
Recent posts

Reform for Roadside Drug Testing in NSW

This report provides an overview of recent data provided to the Legislative Council by the Minister for Police and Counter-terrorism in New South Wales on 10 September 2024, with regards to roadside drug tests conducted over the last 5 years (by Local Area Command), number of positives by drug type and whether there has been […]

Read more

It’s time to be kind and drive change for medicinal cannabis

Imagine having to choose between taking your legally prescribed medication and going to work,doing the school run or getting the shopping that week. Yes, week. This is the stark reality for many Australian medicinal cannabis patients because of the discriminatory drug-driving laws that still exist in most states. Current laws penalise the mere presence of […]

Read more